Showing results (1841-1850 of 1,873) with videos related to
Sort By:
Pageof 188
JACC. Heart Failure|March 4, 2022
Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER TrialScott D Solomon, Muthiah Vaduganathan, Brian L Claggett, et al.Journal of Medical Genetics|December 4, 2009
Mutations in ZIC2 in human holoprosencephaly: description of a novel ZIC2 specific phenotype and comprehensive analysis of 157 individualsBenjamin D Solomon, Felicitas Lacbawan, Sandra Mercier, et al.JAMA|March 29, 2020
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without DiabetesMark C Petrie, Subodh Verma, Kieran F Docherty, et al.The New England Journal of Medicine|September 20, 2019
Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionJohn J V McMurray, Scott D Solomon, Silvio E Inzucchi, et al.JAMA|August 30, 2025
Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing Cardiovascular Hospitalizations in Older Adults: A Prespecified Analysis of the DAN-RSV TrialMats C Højbjerg Lassen, Niklas Dyrby Johansen, Sine H Christensen, et al.European Journal of Preventive Cardiology|April 30, 2026
Respiratory syncytial virus vaccination and risk of respiratory and cardiorespiratory hospitalization in adults with chronic kidney disease: a prespecified analysis of the DAN-RSV trialLisa Steen Duus, Mats C H Lassen, Niklas D Johansen, et al.The New England Journal of Medicine|September 1, 2025
High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older AdultsNiklas Dyrby Johansen, Daniel Modin, Matthew M Loiacono, et al.Circulation. Heart Failure|August 30, 2025
High-Dose vs. Standard-Dose Influenza Vaccine in Heart Failure: A Prespecified Analysis of the DANFLU-2 TrialKristoffer Grundtvig Skaarup, Niklas Dyrby Johansen, Daniel Modin, et al.Journal of the American College of Cardiology|March 3, 2018
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsKaren A Hicks, Kenneth W Mahaffey, Roxana Mehran, et al.JAMA Internal Medicine|January 12, 2026
High-Dose vs Standard-Dose Influenza Vaccine in Older Adults With Diabetes: A Secondary Analysis of the DANFLU-2 Randomized Clinical TrialAnne Bjerg Nielsen, Niklas Dyrby Johansen, Daniel Modin, et al.Pageof 188